American College of Cardiology on Twitter: "ICYMI: The ENTRUST-AF PCI trial showed that edoxaban/clopidogrel was noninferior to vitamin K antagonist-based triple therapy. https://t.co/nSZYOiZOnd #ESCCongress #PCI #AFib https://t.co/EfKHP0I2jp" / Twitter
Davide Capodanno on Twitter: "ENTRUST-AF PCI completes the series of trials of NOAC-DAT vs VKA-TAT. If you want to read more, here is our commentary for The Lancet. https://t.co/326DTeHpiM https://t.co/TXliAi2lAq" / Twitter
JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Antithrombotic Therapy in AF Patients Undergoing PCI - ppt download
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis | SpringerLink
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI | SpringerLink
Direct-acting Anticoagulants in Chronic Coronary Syndromes | ECR Journal
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting
PDF) Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: A pre-specified analysis of the ENTRUST-AF PCI trial
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. | Semantic Scholar
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect
RE-DUAL PCI™ vs PIONEER AF-PCI™
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
RE-DUAL PCI™ vs PIONEER AF-PCI™
ENTRUST AF PCI
The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status - tctmd.com
The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention | Journal of the American College of Cardiology
Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation - American Journal of Cardiology
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based antithrombotic regimen following successful coronary stenting in atrial fibrillation patients
